CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials. For patients ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...
The most important benefit of participating in a clinical trial is that patients get early access to potentially new and successful treatments or screenings before the general public. (Karmanos Cancer ...
Prospective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical management decisions in over 90% of leptomeningeal ...
The drug is currently classified as a Schedule I controlled substance in the United States, leading those seeking treatment ...
AUSTIN, Texas, Nov. 22, 2024 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Plus Therapeutics, Inc. (PSTV) (Nasdaq: PSTV) (“Plus” or the “Company”), will present data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results